Smoking causes lung cancer by delivering dozens of cancer-causing chemicals deep into the lungs, where they physically damage the DNA inside your cells. Men who smoke are 23 times more likely to develop lung cancer than nonsmokers. That enormous risk gap comes down to a chain of biological events: toxic chemicals enter the lungs, bind to DNA, trigger genetic mutations, and disable the body’s normal defenses against abnormal cell growth.
What Happens When Smoke Reaches Your Cells
Tobacco smoke contains more than 7,000 chemicals, and several dozen of them are known carcinogens. Two of the most potent belong to a class called tobacco-specific nitrosamines. These chemicals are not immediately dangerous in the form you inhale them. They’re what scientists call procarcinogens: inert substances that only become harmful after your body tries to process them.
Once inhaled, your cells attempt to break down these chemicals using enzymes that normally help metabolize foreign substances. That metabolic process accidentally converts the nitrosamines into highly reactive molecules that latch onto your DNA. These attachments are called DNA adducts, and they’re essentially chemical scars on your genetic code. The adducts distort the structure of DNA, and when cells copy their DNA to divide, those distortions cause errors in the genetic instructions.
Polycyclic aromatic hydrocarbons, another major group of carcinogens in smoke, cause damage primarily at specific DNA building blocks called guanines. The result is a characteristic type of mutation where one DNA letter gets swapped for another. These aren’t random errors. They follow a recognizable pattern that researchers can trace directly to tobacco exposure, almost like a fingerprint left behind by the chemicals in smoke.
The Genes That Get Damaged
Not all DNA damage leads to cancer. Your cells have built-in error-correction systems, and most mutations are either repaired or occur in stretches of DNA that don’t code for anything important. Cancer develops when mutations hit specific genes that control cell growth.
Two genes matter most in smoking-related lung cancer. The first is a tumor suppressor gene called TP53, sometimes called the “guardian of the genome.” It normally stops damaged cells from multiplying and triggers self-destruction in cells that can’t be repaired. When tobacco chemicals mutate TP53, that safety brake disappears. Damaged cells that should have been eliminated instead keep dividing.
The second is an oncogene called KRAS, which acts like a growth switch. In its normal state, it tells cells when to grow and when to stop. Mutations caused by tobacco carcinogens can lock this switch in the “on” position, pushing cells to multiply continuously. In smokers, about two-thirds of KRAS mutations are a specific type of DNA letter swap (G to T transversion) consistent with damage from the hydrocarbons in smoke. This pattern is far less common in lung cancers that develop in people who have never smoked, which confirms that tobacco chemicals are directly responsible for these particular mutations.
When both of these systems fail in the same cell lineage, you get uncontrolled growth with no functioning off switch. That’s the foundation of a tumor.
How Smoking Disables Your Lungs’ Defenses
Your airways are lined with tiny hair-like structures called cilia that constantly sweep mucus, dust, bacteria, and inhaled particles upward toward your throat, where they can be swallowed or coughed out. This cleaning system is your first line of defense against anything harmful that enters your lungs.
Tobacco smoke paralyzes these cilia. With repeated exposure, the cilia stop functioning effectively, and mucus accumulates in the airways. This is why smokers develop a persistent cough: the body is trying to clear material that the cilia can no longer move. The practical consequence for cancer risk is significant. When cilia aren’t working, carcinogenic particles from each cigarette sit in contact with lung tissue for longer, giving them more time to be absorbed and more opportunity to damage DNA.
Chronic Inflammation Fuels Tumor Growth
Beyond direct DNA damage, smoking creates a state of chronic inflammation in lung tissue that promotes cancer in a different way. Cigarette smoke triggers immune cells in the lungs called macrophages to release a flood of reactive oxygen species, essentially unstable molecules that damage cells and tissues. These reactive molecules activate inflammatory signaling pathways that ramp up the production of proteins like interleukin-8, which recruits more immune cells and sustains the inflammatory cycle.
This matters because chronic inflammation creates an environment that favors tumor development. Inflamed tissue has higher rates of cell turnover, meaning more cell divisions and more chances for DNA-copying errors to occur. The inflammatory signals also promote the growth of new blood vessels and can suppress the immune system’s ability to recognize and destroy abnormal cells. Over years and decades, this pro-inflammatory environment works alongside the direct DNA damage from carcinogens to push normal lung tissue toward cancer.
Which Types of Lung Cancer Smoking Causes
Lung cancer is not a single disease. The two broad categories are small cell lung cancer, which is almost exclusively found in smokers, and non-small cell lung cancer, which accounts for the large majority of cases. Non-small cell lung cancer is further divided into subtypes, including squamous cell carcinoma and adenocarcinoma.
Historically, squamous cell carcinoma and small cell carcinoma had the strongest links to smoking. But adenocarcinoma, which develops in the mucus-producing cells deeper in the lung, has become the most common type overall. Smoking significantly increases the risk of adenocarcinoma as well: male smokers face roughly 19 times the risk of dying from it compared to nonsmokers. Adenocarcinoma surpassed squamous cell carcinoma as the leading type in U.S. cancer registries during the 1980s, partly because its incidence continued rising even as rates of other subtypes began to level off.
Secondhand Smoke and Cancer Risk
You don’t have to smoke to get lung damage from tobacco. People who breathe in secondhand smoke inhale many of the same carcinogens that smokers do, just in lower concentrations. Nonsmokers who live with an active smoker increase their risk of developing lung cancer by 20 to 30 percent. Even brief exposure to secondhand smoke can damage cells in ways that initiate the same cancer-promoting process, because the carcinogens in sidestream smoke (the smoke that drifts off the burning end of a cigarette) undergo the same DNA-binding reactions once inhaled.
How Quitting Changes Your Risk
The DNA damage from smoking accumulates over time, which is why risk is measured in “pack-years,” a calculation based on how many packs per day you smoked multiplied by how many years you smoked. One pack a day for 20 years equals 20 pack-years.
Quitting reverses some of the damage over time. Ten years after quitting, your risk of lung cancer drops to about half that of someone who is still smoking. The risk never fully returns to that of a lifelong nonsmoker, because some DNA mutations are permanent, but the reduction is substantial. Your body regains its ability to repair a portion of the accumulated damage, cilia begin functioning again, and the chronic inflammatory state in lung tissue gradually resolves.
Screening for Early Detection
Because the risk remains elevated even after quitting, the U.S. Preventive Services Task Force recommends annual lung cancer screening with low-dose CT scans for adults aged 50 to 80 who have a 20 pack-year smoking history and either currently smoke or quit within the past 15 years. Once you’ve been smoke-free for 15 years, routine screening is no longer recommended. These scans can catch tumors at an early stage when treatment is far more effective.
How E-Cigarettes Compare
E-cigarettes don’t burn tobacco, so they don’t produce the tar or the thousands of combustion byproducts found in cigarette smoke. Levels of one key cancer-linked compound in e-cigarette users are 97 percent lower than in tobacco smokers. However, research in animal models has shown that e-cigarette aerosol still induces DNA damage in lung, bladder, and heart tissue and reduces the cells’ ability to repair that damage. Nicotine itself, regardless of how it’s delivered, can be converted in the body into the same type of nitrosamine that makes tobacco smoke carcinogenic. The long-term cancer risk from e-cigarettes is not yet clear, but the biological mechanisms for potential harm are present.